175867-59-1

Basic information

• Product Name: Cyclohexanecarboxylic acid, 4-amino-, methyl ester (9CI)
• Synonyms: Cyclohexanecarboxylic acid, 4-amino-, methyl ester (9CI)
• CAS NO: 175867-59-1
• Molecular Formula: C₈H₁₅NO₂
• Molecular Weight: 157.2102
• Product Categories: CARBOXYLICESTER
• Mol File: 175867-59-1.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Cyclohexanecarboxylic acid, 4-amino-, methyl ester (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclohexanecarboxylic acid, 4-amino-, methyl ester (9CI)(175867-59-1)
• EPA Substance Registry System: Cyclohexanecarboxylic acid, 4-amino-, methyl ester (9CI)(175867-59-1)

Safety Data

• Hazardous Substances Data: 175867-59-1(Hazardous Substances Data)

Usage

General Description

Cyclohexanecarboxylic acid, 4-amino-, methyl ester (9CI) is a specific chemical compound with the molecular formula C9H13NO2. It is a derivative of cyclohexanecarboxylic acid, containing an amino group at the 4-position and a methyl ester functional group. Cyclohexanecarboxylic acid, 4-amino-, methyl ester (9CI) has potential applications in various fields, including pharmaceuticals, organic synthesis, and chemical research. It may also be used as a building block for the synthesis of other organic compounds. The specific properties and uses of this chemical may vary depending on its exact structure, purity, and other factors.

Upstream product

• 6297-22-9 4-carbomethoxycyclohexanone 
• 874-61-3 4-oxocyclohexanecarboxylic acid 
• 1776-53-0 4-aminocyclohexanecarboxylic acid 
• 18107-18-1 diazomethyl-trimethyl-silane 
• 150-13-0 4-amino-benzoic acid 
• 67-56-1 methanol 

Downstream Products

• 1202413-10-2 trans methyl 4-(N,N-dibenzylamino)-cyclohexyl-carboxylate 
• 130309-46-5 trans-4-(tert-butoxycarbonylamino)cyclohexane carboxylic acid 
• 863222-18-8 4-isopropylsulfonylaminocyclohexanecarboxylic acid 
• 247568-41-8 2-[4-(methoxycarbonyl)cyclohexylamino]-5-nitro-N-(1,3-benzodioxol-5-ylmethyl)benzamide 
• 126455-18-3 (D,L)-cis 4-guanidinocyclohexylglycine methyl ester dihydrochloride 
• 126385-78-2 methyl (1r,4r)-4-benzamidocyclohexane-1-carboxylate 
• 126455-20-7 (D,L)-cis 4-guanidinocyclohexylglycine 
• 126385-79-3 cis 4-benzoylaminocyclohexanecarboxaldehyde 
• 126385-80-6 trans 4-benzoylaminocyclohexanecarboxaldehyde 
• 126385-82-8 (D,L)-cis 4-aminocyclohexylglycine dihydrochloride 
• 60601-18-5 cis 4-benzoylaminocyclohexanemethanol 
• 60601-17-4 trans 4-benzoylaminocyclohexanemethanol 
• 126385-81-7 4-dibenzoylaminocyclohexanecarboxylate 
• 126385-77-1 methyl (1s,4s)-4-benzamidocyclohexane-1-carboxylate 

Relevant articles and documents

DOPAMINE D3 RECEPTOR ANTAGONISTS COMPOUNDS

The disclosure is directed to novel dopamine D3 receptor antagonists, processes for their preparation, intermediates used in these processes, pharmaceutical compositions containing them and their use in therapy, including treating drug dependency and psychosis.

Discovery of small molecule Mer kinase inhibitors for the treatment of pediatric acute lymphoblastic leukemia

Ectopic Mer expression promotes pro-survival signaling and contributes to leukemogenesis and chemoresistance in childhood acute lymphoblastic leukemia (ALL). Consequently, Mer kinase inhibitors may promote leukemic cell death and further act as chemosensitizers increasing efficacy and reducing toxicities of current ALL regimens. We have applied a structure-based design approach to discover novel small molecule Mer kinase inhibitors. Several pyrazolopyrimidine derivatives effectively inhibit Mer kinase activity at subnanomolar concentrations. Furthermore, the lead compound shows a promising selectivity profile against a panel of 72 kinases and has excellent pharmacokinetic properties. We also describe the crystal structure of the complex between the lead compound and Mer, opening new opportunities for further optimization and new template design.

N-SUBSTITUTED PHENYLACETAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

A compound represented by the formula: (I) wherein R1 represents a methoxy group, a hydroxyl group or a hydrogen atom; R2 represents a hydrogen atom, a C1-4 alkyl group, a C1-4 alkylcarbonyl group or an arylcarbonyl group; and D represents a group represented by the formula (A), (B) or (C) below. (A) (B) (C) This compound is useful as a therapeutic agent for a pain or inflammation induced by any one of various morbid conditions such as neuropathic pain, rheumatoid arthritis and osteoarthritis.